Zusammenfassung
Die gestationsbedingten Trophoblasterkrankungen (GTE) umfassen eine zytogenetisch und klinisch heterogene Gruppe von Krankheitsbildern, die durch eine abnorme Proliferation des trophoblastischen Gewebes gekennzeichnet sind.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Allison KH, Love JE, Garcia RL. (2006) Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med. 130(12): 1875–1877
Azab M, Droz JP, Theodore C et al. (1989) Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer 64: 1829–1818
Bae SN, Kim SJ (1999) Telomerase activity in complete hydatidiform mole. Am J Obstet Gynecol 180 (2): 328–333
Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE. (2006) Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol. 100(3): 511–520
Bagshawe KD (1992) Trophoblastic tumors: diagnostic methods, epidemiology, clinical features and management. In: Coppleson M (ed) Gynecologic oncology. Edinburgh, London, Melbourne, New York, Tokyo: Churchill Livingstone: 1027–1043
Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS (1989) The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynecol 96: 795–802
Batorfi J Vegh G, Szepesi J et al. (2004) How long should patients be followed after molar pregnancy? Analysis of serum hCG followup data. Eur J Obstet Gynecol 112: 95–97
Cheung AN, Shen DH, Khoo US et al. (1998) p21WAF/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. J Clin Pathol 51 (2): 159–162
Chilosi M, Piazzola E, Lestani M et al. (1998) Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78 (3): 269–276
Fulop V, Mok SC, Genest DR et al. (1998) p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 43 (2): 119–127
Horowitz NS, Goldstein DP, Berkowitz RS. (2009) Management of gestational trophoblastic neoplasia.Semin Oncol. 2009 Apr;36(2): 181–189
Jauniaux E (1999) Partial moles: from postnatal to prenatal diagnosis. Placenta 20 (5–6): 379–388
Lavi I, Rao GG, Castrillon DH, Miller DS, Schorge JO (2005) Duration of human chorionic gonadotropin surveillance for parial hydatidiform moles. Am J Obstet Gynecol 192 (5): 1362–1364
Lurain JR (2011) Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 204(1): 11–18
Lurain JR. (2010) Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 203(6): 531–539
Matsui H, Iitsuka Y, Seki K et al. (1998) Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities. Gynecol Obstet Invest 46 (1): 5–8
Merchant SH, Amin MB, Viswanatha DS, Malhotra RK, Moehlenkap C, Joste NE (2005) p57kip2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol 36 (2): 180–186
Molykutty J, Rajalekshmy TN, Balaraman NM et al. (1998) Proliferating cell nuclear antigen (PCNA) expression in gestational trophoblastic disease (GTD). Neoplasma 45 (5): 301–304
Newlands ES, Bagshawe KD, Begent RHJ et al. (1986) Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979–1984). Br J Obstet Gynecol 93: 63–69
Newlands ES, Bower M, Holden L et al. (1998) Management of resistant gestational trophoblastic tumors. J Reprod Med 43 (2): 111– 118
Palmer JR, Drscoll SG, Rosenberg L et al. (1999) Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst 91 (7): 635–640
Sebire NJ, Seckl MJ. (2010) Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles. Current evidence and future directions. J Reprod Med55: 236–246
Smith EB, Weed JC, Tyrey L, Hammond CB (1982) Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid. Am J Obstet Gynecol 144: 88–92
Soper JT, Evans AC, Clarke-Pearson DL et al (1994) Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide- vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol 83 (1): 113–117
Theodore C, Azab M, Droz JP et al. (1989) Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide. Cancer 64: 1824–1828
Wang CM, Dixon PH, Decordova S, Hodges MD, Sebire NJ, Ozalp S, Fallahian M, Sensi A, Ashrafi F, Repiska V, Zhao J, Xiang Y, Savage PM, Seckl MJ, Fisher RA. (2009) Identification of 13 novel NLRP7 mutations in 20 families with recurrenthydatidiform mole; missense mutations cluster in the leucine-rich region. J Med Genet. 46(8): 569–575
Wong LC, Choo YC, Ma HK (1985) Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 152: 59–62
Woolas RP, Bower M, Newlands ES et al. (1998) Influence of chemotherapy for gestational trophoblastic disease on pregnancy outcome. Br J Obstet Gynecol 105 (9): 1032–1035
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Costa, S.D. (2013). Gestationsbedingte Trophoblasterkrankungen (Blasenmole und Chorionkarzinom). In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20923-9_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-20923-9_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20922-2
Online ISBN: 978-3-642-20923-9
eBook Packages: Medicine (German Language)